Table of Contents

company-logo

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.

Perspective Therapeutics Dividend Announcement

• Perspective Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Perspective Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Perspective Therapeutics Dividend History

Perspective Therapeutics Dividend Yield

Perspective Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Perspective Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Perspective Therapeutics Financial Ratios

P/E ratio-48.24
PEG ratio4.34
P/B ratio10.48
ROE-20.69%
Payout ratio0.00%
Current ratio2.67
Quick ratio2.55
Cash Ratio2.22

Perspective Therapeutics Dividend FAQ

Does Perspective Therapeutics stock pay dividends?
Perspective Therapeutics does not currently pay dividends to its shareholders.
Has Perspective Therapeutics ever paid a dividend?
No, Perspective Therapeutics has no a history of paying dividends to its shareholders. Perspective Therapeutics is not known for its dividend payments.
Why doesn't Perspective Therapeutics pay dividends?
There are several potential reasons why Perspective Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Perspective Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Perspective Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Perspective Therapeutics a dividend aristocrat?
Perspective Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Perspective Therapeutics a dividend king?
Perspective Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Perspective Therapeutics a dividend stock?
No, Perspective Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Perspective Therapeutics stocks?
To buy Perspective Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Perspective Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.